A 2026 stock outlook for Ryan Specialty (NYSE: RYAN). How a wholesale excess & surplus (E&S) and specialty insurance broker actually makes money, why the hard market powered its growth, the M&A roll-up model, organic growth and EBITDAC margin, plus rate-softening, integration, leverage and key-person risks.
PVH Corp (PVH) stock outlook for 2026. A deep look at the Calvin Klein and Tommy Hilfiger brand engines, the PVH+ direct-to-consumer transformation, wholesale weakness and European consumer exposure, inventory and tariff risk, and why the stock trades at such a low multiple relative to its brand value.
Carlyle Group (NASDAQ: CG) 2026 stock outlook. A deep look at the private equity, credit and infrastructure segments, fee-related earnings (FRE) versus performance carry, the fundraising cycle, the valuation gap with Blackstone, KKR, Apollo and Ares, plus rate and key-person risk.
Boot Barn (BOOT) 2026 stock analysis: the western and workwear category-killer store model, exclusive-brand margin engine, unit-growth runway, oil-patch and discretionary-consumer exposure, and the expansion-execution risk that defines the stock.
WHR (Whirlpool) 2026 stock outlook. A grounded look at Maytag and KitchenAid brand scale in North America, replacement-demand cash flows, dividend sustainability, housing and rate-cycle exposure, Samsung/LG/Haier low-cost competition, and the balance-sheet debt question.
A.O. Smith (AOS) 2026 stock analysis: the North American water-heater replacement-demand oligopoly cash cow, water treatment growth, the two faces of China and India, steel and tariff risk, and what a Dividend Aristocrat's capital allocation tells investors.
GKOS (Glaukos) 2026 stock outlook. A deep qualitative look at its glaucoma MIGS leadership with iStent, the iDose sustained drug-delivery pivot, the Epioxa corneal-disease pipeline, and the reimbursement, competition, and cash-burn growth-stock risks.
United Therapeutics (UTHR) stock outlook for 2026. A qualitative deep dive into the treprostinil pulmonary hypertension franchise, Tyvaso DPI growth, Liquidia and sotatercept competition, patent-cliff risk, and the long-shot optionality of manufactured organs and xenotransplantation.
Paylocity (PCTY) 2026 stock analysis: mid-market cloud payroll and HCM SaaS, subscription plus client-fund float income, module expansion, real free cash flow, competition from ADP, Paycom, and Workday, employment sensitivity, and valuation risk.
Samjin Pharmaceutical (KOSPI 005500) 2026 stock outlook. A deep look at the steady cash flow from its clopidogrel antithrombotic and Geworin OTC analgesic, the option value of the Magok R&D new-drug pipeline, and the drag from generic drug-pricing cuts and originator competition.
IS Dongseo (KRX: 010780) stock outlook for 2026. A sum-of-the-parts breakdown of the Eileen's Deul housing arm, the INUS ceramics and sanitaryware business, and the environmental engine of waste incineration, landfill, and battery recycling, plus the property-cycle, rate, and PF risks that anchor the valuation.
BH Co. (KOSPI 090460) 2026 stock outlook. A deep, qualitative look at its OLED flexible printed circuit board position in the Apple supply chain, the automotive and EV-battery FPCB diversification push, single-customer concentration, ASP pressure, and won-dollar currency exposure for foreign investors.
Mirae Asset Life (085620) 2026 stock outlook. A deep qualitative look at Korea's variable- and pension-centric asset-management-style life insurer: its fee-income model, IFRS17 CSM and rate sensitivity, the low-growth value-trap risk, and the buyback-and-dividend catalyst that could re-rate the shares.
Contentree JoongAng (036420) 2026 stock analysis: the SLL multi-label drama studio supplying Netflix and global OTT, the Megabox cinema segment, production-cost inflation and hit-driven volatility, the accumulated losses and debt load, and how this Korea-listed content name compares with Studio Dragon and CJ ENM.
Korea Line Corporation (KOSPI: 005880) 2026 stock outlook. A shipping analyst breaks down the long-term contract (COA) dry-bulk and LNG cash floor, SM Group ownership, Baltic Dry Index cycle exposure, debt and bunker-fuel risk, and how it stacks up against Pan Ocean and HMM.
K Car (KRX 381970) stock outlook for 2026. A deep qualitative look at the direct-purchase certified used-car retail model, its scale and trust-brand moat, Hyundai and Kia entering certified pre-owned, the used-car price cycle, rates and discretionary-demand risk, and the metrics that matter.
Seongwoo Hitech (015750) 2026 stock outlook. A deep qualitative look at the Hyundai-Kia captive body-parts model, hot-stamping and giga-steel lightweighting technology, new EV battery-housing revenue, and the risks of single-customer dependence, thin margins, steel costs, and currency swings for the KOSDAQ auto-parts supplier.
Voronoi (KOSDAQ 310210) 2026 stock outlook. A deep look at its brain-penetrant precision kinase oncology platform, the out-licensing royalty and milestone business model, the clinical-binary, cash-burn and dilution risks, Korean biotech peer comparison, and what foreign investors should know about KRW currency exposure.
A 2026 outlook on KCTech (281820, KOSPI), the Korean chip materials and equipment supplier. We dig into its CMP slurry localization moat, the lumpy fab-capex exposure of its cleaning and deposition tools, Chinese slurry competition, customer concentration on Samsung and SK Hynix, and what a foreign investor should watch.
A practical 2026 guide to anesthesia error malpractice claims in the US: what qualifies as negligence, common error types, whether the anesthesiologist, CRNA, or hospital is liable, damages, statute of limitations, and how to choose a lawyer.
A practical 2026 guide to dental malpractice claims in the U.S.: the four elements you must prove, bad outcome vs. negligence, common case types like nerve injury and wrong-tooth extraction, damages, the lawsuit process, choosing a lawyer, fees, and the statute of limitations.
Choosing between a pension lump sum (rolled into an IRA) and a monthly annuity in 2026: how interest rates, longevity, spousal protection, PBGC limits, inflation, rollover taxes, and break-even age should drive your once-and-done decision.
A practical 2026 guide to Single Premium Immediate Annuities (SPIAs): how they work, payout options, exclusion-ratio taxation, SPIA vs bond and CD ladders, when a SPIA makes sense, and the mistakes to avoid.
A practical 2026 guide to HO-6 condo insurance: what the walls-in policy covers versus the HOA master policy, how to size Coverage A, loss assessment, cost ranges, and the mistakes that leave owners exposed.